Works by Uemura, Hirotsugu


Results: 186
    1

    Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. 333, doi. 10.1093/oncolo/oyac243
    By:
    • Larkin, James;
    • Oya, Mototsugu;
    • Martignoni, Marcella;
    • Thistlethwaite, Fiona;
    • Nathan, Paul;
    • Ornstein, Moshe C;
    • Powles, Thomas;
    • Beckermann, Kathryn E;
    • Balar, Arjun V;
    • McDermott, David;
    • Gupta, Sumati;
    • Philips, George K;
    • Gordon, Michael S;
    • Uemura, Hirotsugu;
    • Tomita, Yoshihiko;
    • Wang, Jing;
    • Michelon, Elisabete;
    • Pietro, Alessandra di;
    • Choueiri, Toni K
    Publication type:
    Article
    2
    3
    4

    The gut microbiota associated with high‐Gleason prostate cancer.

    Published in:
    Cancer Science, 2021, v. 112, n. 8, p. 3125, doi. 10.1111/cas.14998
    By:
    • Matsushita, Makoto;
    • Fujita, Kazutoshi;
    • Motooka, Daisuke;
    • Hatano, Koji;
    • Fukae, Shota;
    • Kawamura, Norihiko;
    • Tomiyama, Eisuke;
    • Hayashi, Yujiro;
    • Banno, Eri;
    • Takao, Tetsuya;
    • Takada, Shingo;
    • Yachida, Shinichi;
    • Uemura, Hirotsugu;
    • Nakamura, Shota;
    • Nonomura, Norio
    Publication type:
    Article
    5

    Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.

    Published in:
    Cancer Science, 2020, v. 111, n. 3, p. 907, doi. 10.1111/cas.14294
    By:
    • Uemura, Motohide;
    • Tomita, Yoshihiko;
    • Miyake, Hideaki;
    • Hatakeyama, Shingo;
    • Kanayama, Hiro‐omi;
    • Numakura, Kazuyuki;
    • Takagi, Toshio;
    • Kato, Tomoyuki;
    • Eto, Masatoshi;
    • Obara, Wataru;
    • Uemura, Hirotsugu;
    • Choueiri, Toni K.;
    • Motzer, Robert J.;
    • Fujii, Yosuke;
    • Kamei, Yoichi;
    • Umeyama, Yoshiko;
    • Pietro, Alessandra;
    • Oya, Mototsugu
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Inflammatory myofibroblastic tumor of the prostate.

    Published in:
    2024
    By:
    • Fukiage, Ken;
    • Fujita, Kazutoshi;
    • Toyoda, Shingo;
    • Nishimoto, Mitsuhisa;
    • Kikuchi, Takashi;
    • Chikugo, Takaaki;
    • Yoshimura, Kazuhiro;
    • Esa, Atsunobu;
    • Ito, Akihiko;
    • Uemura, Hirotsugu
    Publication type:
    Case Study
    12
    13
    14

    Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.769068
    By:
    • Matsumura, Naoki;
    • Fujita, Kazutoshi;
    • Nishimoto, Mitsuhisa;
    • Yamamoto, Yutaka;
    • Kuwahara, Ken;
    • Nagai, Yasuharu;
    • Minami, Takafumi;
    • Hatanaka, Yuji;
    • Nozawa, Masahiro;
    • Morimoto, Yasuhiro;
    • Tahara, Hideo;
    • Uejima, Shigeya;
    • Esa, Atsunobu;
    • Hirayama, Akihide;
    • Yoshimura, Kazuhiro;
    • Uemura, Hirotsugu
    Publication type:
    Article
    15

    Trop-2 in Upper Tract Urothelial Carcinoma.

    Published in:
    Current Oncology, 2022, v. 29, n. 6, p. 3911, doi. 10.3390/curroncol29060312
    By:
    • Tomiyama, Eisuke;
    • Fujita, Kazutoshi;
    • Nakano, Kosuke;
    • Kuwahara, Ken;
    • Minami, Takafumi;
    • Kato, Taigo;
    • Hatano, Koji;
    • Kawashima, Atsunari;
    • Uemura, Motohide;
    • Takao, Tetsuya;
    • Fushimi, Hiroaki;
    • Katayama, Kotoe;
    • Imoto, Seiya;
    • Yoshimura, Kazuhiro;
    • Imamura, Ryoichi;
    • Uemura, Hirotsugu;
    • Nonomura, Norio
    Publication type:
    Article
    16
    17

    A malignant Leydig cell tumor of the testis.

    Published in:
    International Urology & Nephrology, 2006, v. 38, n. 2, p. 291, doi. 10.1007/s11255-006-6661-8
    By:
    • Sugimoto, Koichi;
    • Matsumoto, Seiji;
    • Nose, Kazuhiro;
    • Kurita, Takashi;
    • Uemura, Hirotsugu;
    • Park, Young-Chol;
    • Hanai, June
    Publication type:
    Article
    18
    19
    20
    21
    22

    A Case Report of Synchronous Triple Cancer Resected Simultaneously.

    Published in:
    Japanese Journal of Clinical Oncology, 1994, v. 24, n. 3, p. 166
    By:
    • Okajima, Eijiro;
    • Ozono, Seiichiro;
    • Nagayoshi, Junichi;
    • Uemura, Hirotsugu;
    • Hirao, Yoshihiko;
    • Nakajima, Yoshiyuki;
    • Nakano, Hiroshige;
    • Yoshida, Masumi;
    • Sugimura, Masahito;
    • Okajima, Eigoro
    Publication type:
    Article
    23
    24
    25

    Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction.

    Published in:
    PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148177
    By:
    • Low, Siew-Kee;
    • Fukunaga, Koya;
    • Takahashi, Atsushi;
    • Matsuda, Koichi;
    • Hongo, Fumiya;
    • Nakanishi, Hiroyuki;
    • Kitamura, Hiroshi;
    • Inoue, Takamitsu;
    • Kato, Yoichiro;
    • Tomita, Yoshihiko;
    • Fukasawa, Satoshi;
    • Tanaka, Tomoaki;
    • Nishimura, Kazuo;
    • Uemura, Hirotsugu;
    • Hara, Isao;
    • Fujisawa, Masato;
    • Matsuyama, Hideyasu;
    • Hashine, Katsuyoshi;
    • Tatsugami, Katsunori;
    • Enokida, Hideki
    Publication type:
    Article
    26
    27
    28
    29

    Fucosylation in Urological Cancers.

    Published in:
    International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13333, doi. 10.3390/ijms222413333
    By:
    • Fujita, Kazutoshi;
    • Hatano, Koji;
    • Hashimoto, Mamoru;
    • Tomiyama, Eisuke;
    • Miyoshi, Eiji;
    • Nonomura, Norio;
    • Uemura, Hirotsugu
    Publication type:
    Article
    30

    Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma.

    Published in:
    International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5390, doi. 10.3390/ijms21155390
    By:
    • Tomiyama, Eisuke;
    • Fujita, Kazutoshi;
    • Rodriguez Pena, Maria Del Carmen;
    • Taheri, Diana;
    • Banno, Eri;
    • Kato, Taigo;
    • Hatano, Koji;
    • Kawashima, Atsunari;
    • Ujike, Takeshi;
    • Uemura, Motohide;
    • Takao, Tetsuya;
    • Yamaguchi, Seiji;
    • Fushimi, Hiroaki;
    • Yoshimura, Kazuhiro;
    • Uemura, Hirotsugu;
    • Netto, George J.;
    • Nonomura, Norio
    Publication type:
    Article
    31

    A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1533, doi. 10.1007/s10147-020-01692-z
    By:
    • Hinata, Nobuyuki;
    • Yonese, Junji;
    • Masui, Satoru;
    • Nakai, Yasutomo;
    • Shirotake, Suguru;
    • Tatsugami, Katsunori;
    • Inamoto, Teruo;
    • Nozawa, Masahiro;
    • Ueda, Kosuke;
    • Etsunaga, Toru;
    • Osawa, Takahiro;
    • Uemura, Motohide;
    • Kimura, Go;
    • Numakura, Kazuyuki;
    • Yamana, Kazutoshi;
    • Miyake, Hideaki;
    • Fukasawa, Satoshi;
    • Ochi, Kenya;
    • Kaneko, Hirokazu;
    • Uemura, Hirotsugu
    Publication type:
    Article
    32

    A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 720, doi. 10.1007/s10147-019-01589-6
    By:
    • Matsubara, Nobuaki;
    • Kimura, Go;
    • Uemura, Hiroji;
    • Uemura, Hirotsugu;
    • Nakamura, Motonobu;
    • Nagamori, Satoshi;
    • Mizokami, Atsushi;
    • Kikukawa, Hiroaki;
    • Hosono, Makoto;
    • Kinuya, Seigo;
    • Krissel, Heiko;
    • Siegel, Jonathan;
    • Kakehi, Yoshiyuki
    Publication type:
    Article
    33

    Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 9, p. 1089, doi. 10.1007/s10147-019-01450-w
    By:
    • Ohyama, Chikara;
    • Kojima, Takahiro;
    • Kondo, Tsunenori;
    • Naya, Yoshio;
    • Inoue, Takamitsu;
    • Tomita, Yoshihiko;
    • Eto, Masatoshi;
    • Hisasue, Shinichi;
    • Uemura, Hirotsugu;
    • Obara, Wataru;
    • Kikuchi, Eiji;
    • Sharma, Padmanee;
    • Galsky, Matthew D.;
    • Siefker-Radtke, Arlene;
    • Grossfeld, Gary;
    • Collette, Sandra;
    • Gooden, Kyna;
    • Kimura, Go
    Publication type:
    Article
    34

    Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 557, doi. 10.1007/s10147-018-01389-4
    By:
    • Uemura, Hirotsugu;
    • Uemura, Hiroji;
    • Nagamori, Satsohi;
    • Wakumoto, Yoshiaki;
    • Kimura, Go;
    • Kikukawa, Hiroaki;
    • Yokomizo, Akira;
    • Mizokami, Atsushi;
    • Kosaka, Takeo;
    • Masumori, Naoya;
    • Kawasaki, Yoshihide;
    • Yonese, Junji;
    • Nasu, Yasutomo;
    • Fukasawa, Satoshi;
    • Sugiyama, Takayuki;
    • Kinuya, Seigo;
    • Hosono, Makoto;
    • Yamaguchi, Iku;
    • Akagawa, Takashi;
    • Matsubara, Nobuaki
    Publication type:
    Article
    35

    Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 173, doi. 10.1007/s10147-017-1176-0
    By:
    • Nobuaki Matsubara;
    • Satsohi Nagamori;
    • Yoshiaki Wakumoto;
    • Hirotsugu Uemura;
    • Go Kimura;
    • Akira Yokomizo;
    • Hiroaki Kikukawa;
    • Atsushi Mizokami;
    • Takeo Kosaka;
    • Naoya Masumori;
    • Yoshihide Kawasaki;
    • Junji Yonese;
    • Yasutomo Nasu;
    • Satoshi Fukasawa;
    • Takayuki Sugiyama;
    • Seigo Kinuya;
    • Makoto Hosono;
    • Iku Yamaguchi;
    • Hirokazu Tsutsui;
    • Hiroji Uemura
    Publication type:
    Article
    36
    37
    38
    39
    40

    Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2014, v. 19, n. 5, p. 946, doi. 10.1007/s10147-013-0638-2
    By:
    • Matsuyama, Hideyasu;
    • Shimabukuro, Tomoyuki;
    • Hara, Isao;
    • Kohjimoto, Yasuo;
    • Suzuki, Kazuhiro;
    • Koike, Hidekazu;
    • Uemura, Hirotsugu;
    • Hayashi, Taiji;
    • Ueno, Munehisa;
    • Kodaira, Kiichiro;
    • Tomita, Yoshihiko;
    • Sakurai, Toshihiko;
    • Shimizu, Nobuaki
    Publication type:
    Article
    41

    Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis.

    Published in:
    International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 693, doi. 10.1007/s10147-013-0604-z
    By:
    • Nozawa, Masahiro;
    • Inagaki, Takeshi;
    • Nagao, Kazuhiro;
    • Nishioka, Tsukasa;
    • Komura, Takahiro;
    • Esa, Atsunobu;
    • Kitagawa, Michio;
    • Imanishi, Masaaki;
    • Uekado, Yasunari;
    • Ogawa, Takatoshi;
    • Kajikawa, Hiroshi;
    • Uejima, Shigeya;
    • Matsuyama, Hideyasu;
    • Hara, Isao;
    • Uemura, Hirotsugu
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 4, p. 342, doi. 10.1111/iju.15368
    By:
    • Fukuokaya, Wataru;
    • Koike, Yuhei;
    • Yata, Yuji;
    • Komura, Kazumasa;
    • Uchimoto, Taizo;
    • Tsujino, Takuya;
    • Saruta, Masanobu;
    • Takahara, Kiyoshi;
    • Fujita, Kazutoshi;
    • Minami, Takafumi;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Ohno, Yoshio;
    • Uemura, Hirotsugu;
    • Shiroki, Ryoichi;
    • Azuma, Haruhito;
    • Kimura, Takahiro
    Publication type:
    Article
    48

    Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 3, p. 194, doi. 10.1111/iju.15362
    By:
    • Mori, Kazuyuki;
    • Hatakeyama, Shingo;
    • Enokida, Hideki;
    • Miyake, Hideaki;
    • Kikuchi, Eiji;
    • Nishiyama, Hiroyuki;
    • Ichikawa, Tomohiko;
    • Kamai, Takao;
    • Kaji, Yasushi;
    • Kume, Haruki;
    • Kondo, Tsunenori;
    • Matsuyama, Hideyasu;
    • Masumori, Naoya;
    • Kawauchi, Akihiro;
    • Takenaka, Atsushi;
    • Uemura, Hirotsugu;
    • Eto, Masatoshi;
    • Nonomura, Norio;
    • Fujii, Yasuhisa;
    • Hinotsu, Shiro
    Publication type:
    Article
    49

    Real‐world outcomes of avelumab plus axitinib as first‐line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J‐DART).

    Published in:
    International Journal of Urology, 2024, v. 31, n. 3, p. 265, doi. 10.1111/iju.15345
    By:
    • Kato, Taigo;
    • Nakano, Yuzo;
    • Hongo, Fumiya;
    • Katano, Hidenori;
    • Miyagawa, Tomoaki;
    • Ueda, Kosuke;
    • Azuma, Haruhito;
    • Nozawa, Masahiro;
    • Hinata, Nobuyuki;
    • Hori, Junichi;
    • Otoshi, Taiyo;
    • Shimizu, Nobuaki;
    • Aizawa, Mana;
    • Osada, Shingo;
    • Matsui, Akiko;
    • Oya, Mototsugu;
    • Eto, Masatoshi;
    • Tomita, Yoshihiko;
    • Shinohara, Nobuo;
    • Uemura, Hirotsugu
    Publication type:
    Article
    50